K. Melissa Hallow

581 total citations
26 papers, 434 citations indexed

About

K. Melissa Hallow is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, K. Melissa Hallow has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 9 papers in Nephrology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in K. Melissa Hallow's work include Cardiovascular Function and Risk Factors (8 papers), Chronic Kidney Disease and Diabetes (8 papers) and Diabetes Treatment and Management (7 papers). K. Melissa Hallow is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Chronic Kidney Disease and Diabetes (8 papers) and Diabetes Treatment and Management (7 papers). K. Melissa Hallow collaborates with scholars based in United States, Sweden and Netherlands. K. Melissa Hallow's co-authors include Gabriel Helmlinger, Yeshitila Gebremichael, Volker Vallon, H. Daniel Ou‐Yang, Samir N. Ghadiali, Huseyin C. Yalcin, Ming‐Tzo Wei, Peter J. Greasley, David W. Boulton and Hiddo J.L. Heerspink and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Journal of Applied Physiology.

In The Last Decade

K. Melissa Hallow

24 papers receiving 428 citations

Peers

Countries citing papers authored by K. Melissa Hallow

Since Specialization

Citations

This map shows the geographic impact of K. Melissa Hallow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Melissa Hallow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Melissa Hallow more than expected).

Fields of papers citing papers by K. Melissa Hallow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Melissa Hallow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Melissa Hallow. The network helps show where K. Melissa Hallow may publish in the future.

Co-authorship network of co-authors of K. Melissa Hallow

This figure shows the co-authorship network connecting the top 25 collaborators of K. Melissa Hallow. A scholar is included among the top collaborators of K. Melissa Hallow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Melissa Hallow. K. Melissa Hallow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis 2024 ·Frontiers in Pharmacology ·K. Melissa Hallow, Peter J. Greasley, Hiddo J.L. Heerspink, (unknown)	0
2	Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis 2024 ·Frontiers in Pharmacology ·(unknown), Peter J. Greasley, (unknown), David W. Boulton, Bengt Hamrén, K. Melissa Hallow	1
3	The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial 2024 ·British Journal of Pharmacology ·(unknown), Peter J. Greasley, Hiddo J. Lambers Heerspink, Phil Ambery, Christine Ahlström, Bengt Hamrén, Anis A. Khan, David W. Boulton, K. Melissa Hallow	4
4	Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling 2023 ·PLoS Computational Biology ·Sanchita Basu, (unknown), Jonathan R. Murrow, K. Melissa Hallow	3
5	A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone 2022 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), K. Melissa Hallow	6
6	Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression 2021 ·Frontiers in Physiology ·K. Melissa Hallow, Charles H. Van Brackle, (unknown), Sergey Ermakov	6
7	Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis 2021 ·The Journal of Clinical Pharmacology ·(unknown), Sanchita Basu, Weifeng Tang, Robert C. Penland, Peter J. Greasley, Jan Oscarsson, David W. Boulton, K. Melissa Hallow	3
8	Renal Effects of Dapagliflozin in People with and without Diabetes with Moderate or Severe Renal Dysfunction: Prospective Modeling of an Ongoing Clinical Trial 2020 ·Journal of Pharmacology and Experimental Therapeutics ·K. Melissa Hallow, David W. Boulton, Robert C. Penland, Gabriel Helmlinger, (unknown), Daniël H. van Raalte, Hiddo J.L. Heerspink, Peter J. Greasley	10
9	Cardiac and renal function interactions in heart failure with reduced ejection fraction: A mathematical modeling analysis 2020 ·PLoS Computational Biology ·(unknown), Sanchita Basu, K. Melissa Hallow	15
10	Predicted Cardiac Hemodynamic Consequences of the Renal Actions of SGLT2i in the DAPA‐HF Study Population: A Mathematical Modeling Analysis 2020 ·The Journal of Clinical Pharmacology ·(unknown), Weifeng Tang, Peter J. Greasley, Robert C. Penland, David W. Boulton, K. Melissa Hallow	11
11	Mathematical model of hemodynamic mechanisms and consequences of glomerular hypertension in diabetic mice 2018 ·npj Systems Biology and Applications ·(unknown), Christine Ahlström, Rasmus Jansson‐Löfmark, Ulrika Johansson, Gabriel Helmlinger, K. Melissa Hallow	4
12	Benchmarking renin suppression and blood pressure reduction of direct renin inhibitor imarikiren through quantitative systems pharmacology modeling 2018 ·Journal of Pharmacokinetics and Pharmacodynamics ·Yeshitila Gebremichael, Gëzim Lahu, Majid Vakilynejad, K. Melissa Hallow	6
13	Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers 2018 ·Diabetes Obesity and Metabolism ·Hiddo J.L. Heerspink, C. David Sjöström, Silvio E. Inzucchi, K. Melissa Hallow, Valerie A. Cain, Peter Rossing, Bergur V. Stefánsson, Peter Sartipy	16
14	Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction 2017 ·Toxicological Sciences ·Yeshitila Gebremichael, James Lu, Harish Shankaran, Gabriel Helmlinger, Jerome T. Mettetal, K. Melissa Hallow	21
15	Model‐Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin 2017 ·The Journal of Clinical Pharmacology ·(unknown), K. Melissa Hallow	23
16	Analysis of Hypertension Control Rates Among Participants in the Georgia Hypertension Management and Outreach Program 2017 ·SHILAP Revista de lepidopterología ·(unknown), Jean O’Connor, (unknown), (unknown), (unknown), K. Melissa Hallow	1
17	Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis 2017 ·American Journal of Physiology-Renal Physiology ·K. Melissa Hallow, Yeshitila Gebremichael, Gabriel Helmlinger, Volker Vallon	80
18	Mathematical Model‐based Analysis of the Acute and Chronic Mechanisms of Diabetic Hyperfiltration 2016 ·The FASEB Journal ·K. Melissa Hallow, Volker Vallon	1
19	Exposure-response modeling of flow-mediated dilation provides an unbiased and informative measure of endothelial function 2016 ·Journal of Applied Physiology ·Charles H. Van Brackle, Ryan A. Harris, K. Melissa Hallow	5
20	A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model 2014 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·K. Melissa Hallow, Arthur Lo, (unknown), Manoj C. Rodrigo, Sergey Ermakov, Stuart Friedman, Héctor De León, A. Sarkar, Yuan Xiong, R. Sarangapani, Henning Schmidt, Randy L. Webb, Anna Kondic	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact